AOII Accepts Arthritis Foundation’s 2019 Corporate Impact Award
It was with great honor that AOII accepted the Arthritis Foundation’s Corporate Impact Award on September 13 during the Arthritis Foundation’s Live Yes! Conference of Champions. Please read the following notification letter from AF President and CEO Ann Palmer.
Dear Crystal, Andrea, Troy and Kristie,
I’m excited to let you know that Alpha Omicron Pi Fraternity & Foundation (AOII) has been chosen to receive the Arthritis Foundation’s 2019 Corporate Impact Award!
This well-deserved award will be presented at our Live Yes! Conference of Champions, happening Sept. 13-15 in Atlanta. Champions of the arthritis patient community, our mission’s leading volunteers and other major partners will be there to salute you!
The Corporate Impact Award is the highest recognition given to a company or organization dedicated to making a lasting impact in the fight to conquer arthritis. We’re thrilled to honor AOII for your members’ unwavering commitment through the years.
Since 1967, AOII has been a steadfast partner in our journey to a cure. From your passionate involvement in Walk to Cure Arthritis and Jingle Bell Run… to the distribution of pandas that comfort kids with arthritis… to your generous support of youth at juvenile arthritis camps and the annual JA Conference, AOII brings light and hope to everyone battling this disease. The donations and awareness you raise have fueled our fight for the 54 million Americans who battle the pain of arthritis every day. Alpha Omicron Pi has made a tremendous impact on the arthritis community — and we want to recognize your life-changing contributions.
Again, thank you for your service to the arthritis community and for your outstanding support of the collective efforts. AOII is a true Champion of Yes, and we look forward to honoring you this fall!
Feature photo: Andrea Dill, AOII Foundation Board President, Laurie Stewart, Arthritis Foundation National Board Chair, Crystal Combs, AOII International President, and Ann Palmer, Arthritis Foundation President & CEO